Durability Analysis of a Self-Expanding Transcatheter Aortic Valve Through 30 Years of Accelerated Wear Testing.

Guilherme Attizzani, Marco Frazzetto, Ole De Backer, Danny Dvir, Vanessa Garlepp, Tim Kelley, Kendra J Grubb, Gilbert H L Tang

Abstract read

PubMed Full text at PMC Publisher

In one paragraph

Article in Structural heart : the journal of the Heart Team, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guilherme AttizzaniDivision of Cardiology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio, USA.

Marco FrazzettoDivision of Cardiology, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio, USA.

Ole De BackerThe Heart Center, Rigshospitalet, Copenhagen, Denmark.

Danny DvirInterventional Cardiology Department, Shaare Zedek Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.

Vanessa GarleppMedtronic, Mounds View, Minnesota, USA.

Tim KelleyMedtronic, Mounds View, Minnesota, USA.

Kendra J GrubbMedtronic, Mounds View, Minnesota, USA.

Gilbert H L TangDepartment of Cardiovascular Surgery, Mount Sinai Health System, New York, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

•First reported 30-year in vitro accelerated wear testing data for a THV.•All Evolut PRO + valves met ISO hydrodynamic criteria through 20 years of testing.•At least one valve per size maintained performance through 30 years of testing.•Failures manifested in a consistent pattern, suggesting a shared mechanism.•Testing is ongoing until all valves fail.

Indexed as

Heart valve prosthesisProsthesis durabilityTranscatheter aortic valve replacement

Identifiers

PMID42667054

DOI10.1016/j.shj.2026.101084

PMCPMC13524458

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.